BioToken: First DNA-Backed Crypto Launches, Letting Users Monetize Genetic Data Securely

In a move that's shaking up both the biotech and crypto worlds, Swiss startup GeneVault has officially launched BioToken, the world's first cryptocurrency backed by encrypted genetic data.

Instead of selling genetic information to corporations or research firms, individuals can now tokenize and control access to their DNA, renting it to scientists, pharmaceutical companies, and medical researchers through smart contracts.

How It Works:

• Users upload their raw DNA data (anonymized and encrypted) into GeneVault’s private blockchain.

• They mint BioTokens representing their genomic information.

• Researchers or companies must pay in BioTokens to access specific gene sets for study, with the original owner receiving royalty-like payouts.

• Full transparency and consent layers ensure that users decide exactly who can access their genome — and for what purpose.

Why It’s Revolutionary:

• First time individuals directly profit from the multibillion-dollar genomics industry.

• Eliminates middlemen like third-party DNA testing companies.

• Built on a zero-knowledge proof system, ensuring privacy even when monetized.

"We believe that your DNA should earn for you, not exploit you," said Dr. Luca Reinhardt, CEO of GeneVault.

Already, seven major pharma companies have signed pilot agreements to start using BioToken pools for research into rare genetic diseases.